450
Participants
Start Date
August 26, 2013
Primary Completion Date
May 17, 2018
Study Completion Date
August 29, 2028
Olaparib 300mg tablets
Olaparib/placebo tablets p.o 300mg twice daily for up to 2 years or until objective radiological disease progression as per RECIST as assessed by the Investigator. Patients with evidence of stable disease (or those who have progressed), may continue on treatment beyond 2 years, if in the patient's best interest. Dose reduction to 250mg and subsequently 200mg is permitted following confirmation of toxicity.
Research Site, Columbus
Research Site, Guangzhou
Clearview Cancer Institute, Huntsville
Providence Cancer Center, Anchorage
St. Joseph's Hospital & Medical Center, Phoenix
Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles, Los Angeles
Kaiser Permanente, Oakland
Kaiser Permanente, Roseville
Stanford Women's Cancer Center, Stanford
Babak Edraki, Walnut Creek
University of Colorado, Aurora
Univ of Connecticut Health Center, Farmington
Smilow Cancer Hospital at Yale New Haven, New Haven
Florida Hospital Cancer Institute, Orlando
Gynecologic Cancer Center, Orlando
H Lee Moffitt Cancer Center and Research Institute, Tampa
Northside Hospital, Atlanta
Northeast Georgia Medical Center, Gainesville
Nancy N. & J.C. Lewis Cancer and Research Pavillion, Savannah
The Queen's Medical Center, Honolulu
University of Hawaii, Honolulu
Northwestern University, Chicago
Univ Chicago Medical Center, Chicago
Advocate Lutheran General Hospital, Park Ridge
Indiana University, Indianapolis
St. Vincent Hospital & Health Care Center, Indianapolis
Northern Indiana Cancer Research Consortium, Mishawaka
McFarland Clinic, P.C., Ames
Norton Cancer Institute Research, Louisville
Maine Medical Partners, Scarborough
Greater Baltimore Medical Center, Baltimore
Johns Hopkins, Baltimore
Walter Reed National Military Medical Center, Bethesda
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
Henry Ford Health System, Detroit
Gynecologic Oncology of West MI, PLLC, Grand Rapids
Minnesota Oncology Hematology, PA, Edina
Mayo Clinic - Rochester, MN, Rochester
University of Mississippi Medical Center, Jackson
Washington University School of Medicine, St Louis
Missouri Valley Cancer Consortium CCOP, Omaha
Nebraska Methodist Hospital, Omaha
Womens Cancer Center of Nevada, Las Vegas
MD Anderson at Cooper Cancer Center, Camden
John Theurer Cancer Center, Hackensack
University of New Mexico, Albuquerque
Women's Cancer Care Associates, Albany
Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center, New York
Mount Sinai Medical Center - New York, New York
Perlmutter Cancer Center, New York
Hope Women's Cancer Centers, Asheville
UNC Chapel Hill, Chapel Hill
Levine Cancer Institute, Charlotte
Duke University Medical Center, Durham
Sanford Roger Maris Cancer Center, Fargo
Aultman Hospital, Canton
Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland
Cleveland Clinic Foundation, Cleveland
University Hospital Case Medical Center, Cleveland
Kettering Medical Center, Kettering
Hillcrest Hospital Cancer Center, Mayfield Heights
Peggy and Charles Stephenson Cancer Center, Oklahoma City
Abington Memorial Hospital, Abington
St. Luke's University Health Network, Bethlehem
The University of Pennsylvania, Philadelphia
Women and Infants Hospital, Providence
South Carolina Oncology Associates, PA, Columbia
Avera Cancer Institute, Sioux Falls
Sanford Clinic Women's Health, Sioux Falls
University of Texas Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
University of Texas Health Science Center of Houston, Houston
University of Virginia, Charlottesville
Virginia Oncology Associates, Norfolk
Carilion Clinic Gynecological Oncology, Roanoke
Aurora Baycare Medical Center, Green Bay
University of Wisconsin-Madison, Madison
Froedtert Memorial Hospital, Milwaukee
Mercy Hospital for Women, Heidelberg
The Royal Womens Hospital, Parkville
Prince of Wales Hospital, Randwick
Centro Diagnóstico Barretos, Barretos
Hospital Araujo Jorge, Goiânia
Centro de Novos Tratamentos Itajai, Itajaí
Hospital de Clinicas de Porto Alegre, Porto Alegre
Irmandade da Santa Casa de Misericordia de Porto Alagre, Porto Alegre
Hospital de Base São José do Rio Preto, São José do Rio Preto
Centro de Referencia da Saude da Mulher, São Paulo
Instituto do Câncer de São Paulo, São Paulo
Juravinski Cancer Centre, Hamilton
London Health Sciences Centre, London
Princess Margaret Cancer Centre, Toronto
Sunnybrook Health Sciences Center, Toronto
CHUM - Hopital Norte-Dame, Montreal
Royal Victoria Hospital, Montreal
Hotel-Dieu de Quebec, Québec
Beijing Cancer Hospital, Beijing
The Tumor Hospital affiliated to China Medical Science Insti, Beijing
1st Hospital of Jilin university, Changchun
Jilin Provincial Cancer Hospital, Changchun
Hunan Cancer Hospital, Changsha
West China Hospital Affiliated to Sichuan University, Chengdu
ChongQing Cancer Hospital, Chongqing
Women's Hospital, Zhejaing University School of Medicine, Hangzhou
The Tumour Hospital of Harbin Medical University, Harbin
Zhejiang Cancer Hospital, Huangzhou, Huangzhou
JINAN, Qi Lu Hosp. of SD Univ., Jinan
Obstetris and Gynecology Hospital of Fudan University, Shanghai
Shanghai Cancer Hospital of Fudan University, Shanghai
The First Affiliated Hospital of Soochow Universit, Suzhou
First affiliated hospital college of XianJiaotong University, Xi'an
Institut Bergonie, Bordeaux
CAC François Baclesse, Caen
69LYON, C Bérard, Onco, Lyon
Centre Catherine de Sienne, Nantes
75PARIS, H Tenon, Onco, Paris
Centre Alexis Vautrin, Vandœuvre-lès-Nancy
Institut Gustave Roussy, Villejuif
Rambam Health Care Campus, Haifa
Sapir Medical Centre, Kfar Saba
Rabin MC, Petah Tikva
Tel-Aviv Sourkasy Medical Center, Tel Aviv
Chaim Sheba Medical Centre, Tel Litwinsky
Bari- Istituto Tumori Giovanni Paolo II, Bari
"Azienda Ospedaliera Cannizzaro", Catania
Istituto Europeo di Oncologia, Milan
Istituto Nazionale Per Cura Tumori - Milano, Milan
Istituto Nazionale Tumori Fondazione Pascale, Napoli
Istituto Oncologico Veneto Irccs, Padua
Istituto Regina Elena-Polo Oncologico Ifo, Roma
Policlinico Universitario A. Gemelli, Roma
Hyogo CC, Akashi-shi
National Cancer Center Hosp, Chūōku
NHO Kyushu CC, Fukuoka
Saitama Med. Univ. Int. Med. C, Hidaka-shi
NHO Shikoku Cancer Center, Matsuyama
Niigata Univ. Med. Dent., Niigata
Hokkaido University Hospital, Sapporo
Shizuoka Cancer Center, Sunto-gun
Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam
Maastricht Universitair Medisch Centrum, Maastricht
Niepubliczny Zaklad Opieki Zdrowotnej Innowacyjna Medycyna, Grzepnica
SPZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii, Olsztyn
Wojewódzki Szpital Specjalistyczny w Olsztynie, Olsztyn
Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw
Szpital Specjalistyczny im. Swietej Rodziny SPZOZ, Warsaw
Udmurtia Republic Clinical Oncology Center, Izhevsk
Chemotherapy Department, Russian Cancer Research Centre, Moscow
State Institution of Heath Omsk Regional Oncology Dispensary, Omsk
Cancer Research Institute, Saint Petersburg
Leningrad Regional Oncology Dispensary, Saint Petersburg
St.Petersburg City Oncology Dispensary, Dept. Gynecology, Saint Petersburg
Research Institute of Oncology RAMS, Tomsk
National Cancer Center, Goyang-si
Asan Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Korea Cancer Center Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Barcelona,H.Vall d´Hebrón,Oncología, Barcelona
Córdoba,H.Reina Sofía,Oncología, Córdoba
H.Llobregat,ICO-Duran i Reynals,Oncología, Hospitalet deLlobregat(Barcelo
Madrid, MD Anderson, Oncología, Madrid
Madrid,H.U.La Paz,Oncología, Madrid
Valencia, IVO, Oncología, Valencia
Valencia,H.C.U.Valencia,Oncología, Valencia
City Hospital, Birmingham, Cancer Trials Team, Birmingham
Addenbrooke's Hospital, Cambridge
Arden Cancer Centre, Coventry
Edinburgh Cancer Research UK Centre, Edinburgh
Cancer Research UK and UCL Cancer Trials Centre, London
Royal Marsden Hospital, London
Royal Marsden Hospital and Institute of Cancer Research, Sutton
Lead Sponsor
GOG Foundation
NETWORK
Myriad Genetic Laboratories, Inc.
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
AstraZeneca
INDUSTRY